Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 508

1.

Immunogenicity of a new, low-cost recombinant hepatitis B vaccine derived from Hansenula polymorpha in adults.

Kulkarni PS, Raut SK, Patki PS, Phadke MA, Jadhav SS, Kapre SV, Dhorje SP, Godse SR.

Vaccine. 2006 Apr 24;24(17):3457-60. Epub 2006 Feb 21.

PMID:
16530299
2.

Hepatitis B virus vaccination for older adults.

Bennett RG, Powers DC, Remsburg RE, Scheve A, Clements ML.

J Am Geriatr Soc. 1996 Jun;44(6):699-703.

PMID:
8642163
3.

Comparative efficacy of two dosages of recombinant hepatitis B vaccine in healthy adolescents in India.

Velu V, Nandakumar S, Shanmugam S, Shankar EM, Thangavel S, Kulkarni PS, Thyagarajan SP.

Pediatr Infect Dis J. 2007 Nov;26(11):1038-41.

PMID:
17984812
4.
6.

Immunogenicity of two recombinant hepatitis B vaccines in older individuals.

Treadwell TL, Keeffe EB, Lake J, Read A, Friedman LS, Goldman IS, Howell CD, DeMedina M, Schiff ER, Jensen DM, et al.

Am J Med. 1993 Dec;95(6):584-8.

PMID:
8259774
7.

Immunogenicity and reactogenicity of two recombinant hepatitis B vaccines in small infants: a randomized, double-blind comparative study.

Sapru A, Kulkarni PS, Bhave S, Bavdekar A, Naik SS, Pandit AN.

J Trop Pediatr. 2007 Oct;53(5):303-7. Epub 2007 May 3.

PMID:
17478542
9.

[Immunogenicity and safety of recombinant yeast-derived hepatitis B vaccine in adults].

Shi J, Wang X, Wang G, Xu Z, Yang Z, Zheng L, Li Z, Guo N, Wu X, Liang Z.

Zhonghua Yu Fang Yi Xue Za Zhi. 2002 Nov;36(6):366-9. Chinese.

PMID:
12641969
10.

Immunogenicity of hepatitis B vaccine in multi-transfused thalassemic patients with and without hepatitis C infection: a comparative study with healthy controls.

Froutan-Pishbijari H, Ghofrani H, Mirmomenm S, Kazemi-Asl S, Nassiri-Toosi M, Farahvash MJ, Toroghi HH, Aminian K, Mansour-Ghanaei F, Bagherzadeh AH.

Med Sci Monit. 2004 Dec;10(12):CR679-83.

PMID:
15567986
11.

Intradermal vaccination of adults with three low doses (2 micrograms) of recombinant hepatitis B vaccine. II. Persistence of immunity and induction of immunologic memory.

Elisbão Mdo C, Baldy JL, Bonametti AM, Reiche EM, Morimoto HK, Pontello R, Matsuo T, Ferelle A, Neves J.

Mem Inst Oswaldo Cruz. 2003 Dec;98(8):1109-13.

PMID:
15049099
12.

Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C.

Wiedmann M, Liebert UG, Oesen U, Porst H, Wiese M, Schroeder S, Halm U, Mössner J, Berr F.

Hepatology. 2000 Jan;31(1):230-4.

PMID:
10613751
13.
14.

[Efficacy of recombinant hepatitis B vaccine and low-dose hepatitis B immune globulin in preventing mother-infant transmission of hepatitis B virus infection].

Xia GL, Gong J, Wang JJ, Meng ZD, Jia ZY, Cao HL, Liu CB.

Zhonghua Liu Xing Bing Xue Za Zhi. 2003 May;24(5):362-5. Chinese.

PMID:
12820927
15.

Immunogenicity of two paediatric doses of monovalent hepatitis B or combined hepatitis A and B vaccine in 8-10-year-old children.

Duval B, Gîlca V, Boulianne N, Deceuninck G, Rochette L, De Serres G.

Vaccine. 2005 Jul 1;23(31):4082-7. Epub 2004 Aug 9.

PMID:
15963363
16.

Immunogenicity of three recombinant hepatitis B vaccines administered to students in three doses containing half the antigen amount routinely used for adult vaccination.

Baldy JL, de Lima GZ, Morimoto HK, Reiche EM, Matsuo T, de Mattos ED, Sudan LC.

Rev Inst Med Trop Sao Paulo. 2004 Mar-Apr;46(2):103-7. Epub 2004 May 5.

17.

[Safety and immunogenicity of Bilive combined hepatitis A and B vaccine].

Zhao YL, Chen YG, Li J, Han GX, Tian C, Liang JL, Li G, Wang ZG, Zhu YG, Tian ZN, Zhang HY, Wan ZJ, Liang ZL, Bi SL.

Zhonghua Liu Xing Bing Xue Za Zhi. 2004 Jun;25(6):470-3. Chinese.

PMID:
15231119
18.

Immunogenicity and safety of a novel yeast Hansenula polymorpha-derived recombinant Hepatitis B candidate vaccine in healthy adolescents and adults aged 10-45 years.

Tregnaghi MW, Voelker R, Santos-Lima E, Zambrano B.

Vaccine. 2010 Apr 30;28(20):3595-601. doi: 10.1016/j.vaccine.2010.02.049. Epub 2010 Feb 26.

PMID:
20189492
19.

Immunogenicity and reactogenicity of the combined hepatitis A and B vaccine in young adults.

Tsai IJ, Chang MH, Chen HL, Ni YH, Lee PI, Chiu TY, Safary A.

Vaccine. 2000 Oct 15;19(4-5):437-41.

PMID:
11027806
20.

Safety and immunogenicity of a novel mammalian cell-derived recombinant hepatitis B vaccine containing Pre-S1 and Pre-S2 antigens in neonates.

Yerushalmi B, Raz R, Blondheim O, Shumov E, Koren R, Dagan R.

Pediatr Infect Dis J. 1997 Jun;16(6):587-92. Erratum in: Pediatr Infect Dis J 1997 Nov;16(11):1037.

PMID:
9194109
Items per page

Supplemental Content

Write to the Help Desk